![N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide](https://static.cymitquimica.com/products/3D/img/FC145515.png "Cliccare per ingrandire")
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
CAS: 59831-65-1
Rif. 3D-FC145515
| 1mg | Fuori produzione | ||
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione |
Informazioni sul prodotto
Nome:
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
Sinonimi:
- Halopemide
- 59831-65-1
- N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide
- N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide
Descrizione:
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide (NFA) is a novel benzodiazepine receptor inverse agonist that has been shown to be a potent inhibitor of fatty acid synthase in vitro and in vivo. NFA has been shown to inhibit the production of gamma aminobutyric acid (GABA) with an IC50 value of 0.8 nM. This drug binds to the GABA receptor with high affinity and inhibits the binding of GABA, which is responsible for its anti-anxiety effects. NFA also blocks the binding of dopamine and other drugs to their receptors, which may contribute to its antidepressant properties.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
416.88 g/mol
Formula:
C21H22ClFN4O2
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
